Biotech & Pharma

Novo Nordisk to slash Wegovy list price in half in 2027

21 sec read14 views0 listens

Novo Nordisk announced it will halve the list price of Wegovy to $675 monthly starting next year, targeting relief for patients facing high insurance deductibles or copays. This move aims to increase accessibility and affordability of the weight-loss drug, potentially broadening its user base significantly.

Read the full article at Endpoints News

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

You Might Like

TravelAug 1953 sec read

How good are Bilt's welcome offers? Earn up to 50,000 points

The article discusses three new Bilt credit cards that offer points for rent and mortgage payments. The key features of each card are as follows: Bilt Palladium Card: Welcome Offer: Earn 50,000 bonus points and receive $300 in Bilt Cash upon approva...

Ali Nemati

Real Estate & HomeJun 531 sec read

Synergy One to merge with APM; Steve Majerus named president

American Pacific Mortgage has finalized a merger with Synergy One Lending to create a mortgage production platform generating $14 billion in annual volume. This consolidation matters to fintech professionals as the new leadership plans to leverage th...

Ali Nemati

E-Commerce & RetailMay 727 sec read

Henry Schein hits ecommerce platform goal in Q1

Henry Schein achieved its goal of consolidating over 80% of U.S. dental e-commerce sales through its new HenrySchein.com platform in Q1, marking a significant milestone for the company's BOLD+1 strategic plan aimed at high-growth areas. This developm...

Ali Nemati